Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > New PR Announcing Initiation of Basket Trial
View:
Post by mikeq113 on May 10, 2022 7:38am

New PR Announcing Initiation of Basket Trial

Big fat nothingburger of a PR initiating the basket trial. If they're confident - they're really not showing it to the greater shareholder base or the market. 


https://www.theratech.com/news-releases/news-release-details/theratechnologies-initiates-basket-portion-th1902-first-human

Comment by palinc2000 on May 10, 2022 8:03am
The only new news even though it was expected is that the last 6 patients did not have any serious adverse effects...The rest of the PR is almost old news
Comment by palinc2000 on May 10, 2022 8:07am
Very very low key... Christian is pleased no more ..Not a single word from Paul....
Comment by palinc2000 on May 10, 2022 8:08am
Comma after pleased
Comment by Wino115 on May 10, 2022 8:12am
At least we know it's done, no issues, and on to the more interesting and informing part of the basket trial. I'll take that. 1.  "..firmly believe" the cell entry is an advantage, so they may have (very speculative) seen data around chemo not going anywhere, thus it must be into the cell. 2. Continue to develop other anti-cancer agents, so maybe they're further along. ...more  
Comment by jfm1330 on May 10, 2022 9:12am
So they did it, a freakin PR with no details on phase Ia. Nothing. We are completely in the dark. 
Comment by jfm1330 on May 10, 2022 9:21am
They give no data, but at the same time they talk about firmly believing, about advantage, about potential, but they come up with nothing to back that. All we know is that they were able to give 30% more than the MTD of docetaxel alone for one cycle. So nothing there about cummulative toxicity. Sorry, this is not serious. It is join us as belivers in the potential based on test on mice. We will ...more  
Comment by Bucknelly21 on May 10, 2022 9:33am
Paul doesn't deserve 2 million a year and phillipe should move on, these guys are stubborn and arrogant, they are completely against learning from past mistakes 
Comment by Trogarzon on May 10, 2022 10:11am
I second that... post the board numbers is someone gets them... hope we strear some sh..
Comment by qwerty22 on May 10, 2022 10:12am
I think you (and Palinc) need to be careful when thinking about DLT. It doesn't mean no AEs. It means no AEs IN THE FIRST CYCLE. It's a definition used in the hunt for the MTD and RP2D and that's all. It may be indicative of a good safety profile but it's a very limited number of doses and not enough to really make that call. When Christian says no DLTs in these six patients he' ...more  
Comment by canadapiet on May 10, 2022 10:19am
And that's it......????!! After nearly 2 years doing a fase 1a, such a fluff pr to announce the go ahead for fase 1b, nothing more!!  Now we can wait another ......months, knowing in the near future they will do a "O O" again????? Because such a "Chinese" partner is not the best thing, cause the FDA is very wary when things come from that side ...more  
Comment by palinc2000 on May 10, 2022 10:37am
 I agree.... It  says nothing about the future....I suppose that risks of adverse effects increase as the number of cycles increase...
Comment by Biobob on May 10, 2022 10:39am
You can suppose what you want ... they leave all the possibilities ot suppositions open to us so we can continue to suppose.. I suppose.
Comment by qwerty22 on May 10, 2022 11:07am
You don't have to suppose about the dose for the expansion phase, it's 300. That's a reasonably good outcome. I think Wino said he was relatively confident they would show that. I wasn't given the trouble they had at 420. That's a small win today. It good to try to ask why they didn't give us any more detail today. I have a simple answer. They don't have a clear ...more  
Comment by PWIB123 on May 10, 2022 11:14am
That's a reasonable take on the PR.
Comment by Wino115 on May 10, 2022 11:35am
That's probably right --not enough patients on long enough and having done the proper scans.  I've relegated learning anything about efficacy to the basket trial a while ago.  I was hoping that with some sort of data around the plasma readings, some safety data, simple things like survivability (how long the longest person was on in 1a), etc... might shed some light on POC issues ...more  
Comment by PWIB123 on May 10, 2022 10:41am
And after a quick pop, we are actually trading down even after yesterday's treacherous share price drop and, while not perfect, a positive press release.  I'm glad I voted all my shares against the entire board.  
Comment by Biobob on May 10, 2022 10:43am
You are so harsh with them... management did make a few calls a few days before AGM and a couiple of board members bought some not so long ago... 
Comment by Bucknelly21 on May 10, 2022 10:51am
Only because compliance before agm is my guess
Comment by qwerty22 on May 10, 2022 11:26am
Again, XBI has done something similar as well this morning.   
Comment by canadapiet on May 10, 2022 11:31am
Appointments in Conjunction With Theratechnologies Annual  "And so we are very happy to be where we are today..........................." :-) !!!!!
Comment by Biobob on May 10, 2022 11:34am
Shure they are happy... who would'nt with what they have to do to deserve the payout... they are celebrating the next 00 in a few days now that they are all clear... new analysts ... from the bank .. shure.. screw me some more with the next OO garanteed....
Comment by qwerty22 on May 10, 2022 4:07pm
THTX and XBI are still mirroring each other for the day except for some extra strength for THTX at the end of the day.
Comment by scarlet1967 on May 10, 2022 10:50pm
From the trial: “Part 1 (dose escalation): will comprise patients with recurrent advanced solid tumors (all comers) that have relapsed or are refractory to standard chemotherapy, surgery, radiation therapy, and for which no known effective therapies exist.” One of the inclusion criteria is: “Have an expected survival of at least 3 months.” So since they are not sharing much let’s speculate ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities